Press Release March 23, 2021CureVac's COVID-19 Vaccine Candidate, CVnCoV, Demonstrates Protection Against SARS-CoV-2 B.1.351 Variant (South African Variant) in Preclinical Challenge Study 0 0 Share
Video News March 19, 2021Expert tells investors to ignore selloff and 'stick with' Big Tech stocks 0 0 Share
Video News January 6, 2021Former Twitter CEO Dick Costolo on the potential for tech regulation 0 0 Share
Video News January 6, 2021Investor Joe Lonsdale on how Georgia Senate runoff races could impact tech stocks 0 0 Share